| Q35655811 | A simple relationship between viral load and survival time in HIV-1 infection |
| Q73023739 | A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable |
| Q81462606 | Activation and coreceptor expression of T lymphocytes in HIV/AIDS patients of China |
| Q36600351 | Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development |
| Q40673497 | Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma |
| Q34056068 | Association between obstructive lung disease and markers of HIV infection in a high-risk cohort |
| Q37629663 | Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach |
| Q27334176 | Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection |
| Q36731541 | CD38 Expression in a Subset of Memory T Cells Is Independent of Cell Cycling as a Correlate of HIV Disease Progression |
| Q36223837 | CD4+ T-cell depletion in HIV infection: killed by friendly fire? |
| Q51009179 | Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment. |
| Q46348850 | Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy |
| Q35187451 | Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs |
| Q58818112 | Decrease in Immune Activation in HIV-Infected Patients Treated with Highly Active Antiretroviral Therapy Correlates with the Function of Hematopoietic Progenitor Cells and the Number of Niave CD4+Cells |
| Q73255218 | Decreased CCR5 Expression on CD4+T Cells of SIV-Infected Sooty Mangabeys |
| Q36414232 | Development of neurological disease is associated with increased immune activation in simian immunodeficiency virus-infected macaques |
| Q39996390 | Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques |
| Q92668726 | Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab |
| Q34699524 | Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective |
| Q34007172 | Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease |
| Q43646296 | HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients |
| Q44555364 | HIV dynamics linked to memory CD4+ T cell homeostasis |
| Q40584444 | HIV, 'an evolving species'. Roles of cellular activation and co-infections |
| Q35133510 | Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment |
| Q33181641 | Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells |
| Q30354991 | Immune activation and viral replication after vaccination with an influenza A H1N1 2009 vaccine in HIV-infected children receiving antiretroviral therapy. |
| Q34387944 | In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? |
| Q37661792 | Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation |
| Q40084953 | Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era. |
| Q43703097 | Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy |
| Q42808088 | Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients |
| Q36553615 | No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts |
| Q48023288 | Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia |
| Q40426684 | Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir. |
| Q33953001 | Quantification of intrinsic residual viral replication in treated HIV-infected patients |
| Q33640197 | Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy |
| Q35229333 | Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression |
| Q53467465 | Role of immune activation in CD4+ T-cell depletion in HIV-1 infected Indian patients. |
| Q37800574 | SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase |
| Q36498174 | Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis |
| Q36498208 | Simian immunodeficiency virus SIVagm dynamics in African green monkeys |
| Q36155358 | Simian immunodeficiency virus-induced alterations in monocyte production of tumor necrosis factor alpha contribute to reduced immune activation in sooty mangabeys |
| Q52067626 | Small variations in multiple parameters account for wide variations in HIV-1 set-points: a novel modelling approach. |
| Q34988818 | Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues |
| Q81057077 | Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand |
| Q52053599 | The role of antigenic stimulation and cytotoxic T cell activity in regulating the long-term immunopathogenesis of HIV: mechanisms and clinical implications. |